p-Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation

Дата публикации: 01-09-2024 00:00:00

This cohort study investigates the utility of plasma markers phosphorylated tau 217 (p-tau217) and β-amyloid 42/40 (Aβ42/40) to predict development of Alzheimer disease–related Aβ pathology in cognitively unimpaired individuals with low brain Aβ levels.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment	0	14.88	14-07-2026
2	La proteína p-tau217 en sangre, clave para predecir el riesgo de Alzheimer en personas sanas con décadas de antelación	0	9.6	15-07-2026
3	Tau Oligomer–Containing Synapses Engulfed by Microglia and Astrocytes in Alzheimer Disease	0	7.6	01-11-2023
4	White Matter Hyperintensities in Alzheimer Disease	0	6.14	01-12-2023
5	Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care	0	5.63	15-10-2024
6	Diagnostic Concordance Between Plasma p-Tau217 and Amyloid-β Biomarkers in Symptomatic Alzheimer's Disease: Evidence From a Chinese Cohort	0	23.04	11-08-2026
7	Exploratory Tau Biomarker Results From a Study of BIIB080 in Alzheimer Disease	0	10.76	01-12-2023
8	Hereditary Alzheimer's: Blood marker for defective neuronal connections rises early	2	8	16-04-2025
9	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
10	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	9.23	15-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 15.37. Источник: archderm.jamanetwork.com.